Government

NHS to end contract with Palantir in 2029

Jamie McKane 3 min read
NHS to end contract with Palantir in 2029

The government has announced that it will extend its NHS contract with Palantir for two more years, after which it will be set to end in March 2029.

The extension aims to give the UK time to find a new provider for a new NHS England’s Federated Data Platform (FDP), the centralised database of patient data which aims to improve efficiency and effectiveness of care across the country.

“We want to give the health and care system more choice, greater resilience and less dependence on any single supplier, as well as the ability to adapt and evolve as new technologies emerge in future, with better value for taxpayers through time,” James Frith, Minister for Health at the DHSC, told MPs in the Commons.

“Our future capability should avoid being locked into any single technology. We need a new approach—one that will boost competition, demand interoperability and diversify NHS technology within a safe and modern regulatory framework.”

“The contract will end in March 2029, when we intend to complete the transition to the new FDP with the additional capabilities,” Frith said.

He said the necessary controls and conditions are in place to migrate to a new platform without disrupting patient care.

The FDP provided by Palantir is already deeply integrated into the NHS, currently live in 142 trusts and 35 integrated care boards, involved in everything from vaccine supply chains to appointment scheduling.

“Trusts and patients are benefiting from those services, and they must remain stable while the future model is designed and procured,” Firth said.

“While future arrangements are developed, and the new procurement process is completed, the current contract will remain for two years, before coming to an end.”

“We want to give the health and care system more choice, greater resilience and less dependence on any single supplier, as well as the ability to adapt and evolve as new technologies emerge in future, with better value for taxpayers through time,” he said.

Controversy over Palantir in the NHS

NHS England’s contract with Palantir has been the subject of much controversy in recent months.

The US data and analytics firm has come under fire over its links to the military operations conducted by Israel in Gaza, as well as over worries of its widespread access to Britons’ personal information considering its incorporation in the United States.

The company recently defended itself against false claims that it sells NHS customer data, with a Palantir UK executive refuting claims that the surveillance technology and AI analytics company holds custody over its customers’ information.

Amnesty International has praised the government’s decision to end its NHS contract with the US tech firm, but said that further work lies ahead in terms of extracting Palantir from the NHS.

“Doctors and nurses dedicate their lives to saving lives. They should never have to work in a health service that partners with a company supporting a military committing genocide,” said Amnesty International UK Crisis Campaigner Tom Guha.

“‘First, do no harm’ should apply not just to NHS staff, but to the companies the NHS contracts with.”

He said this is welcome progress, but that the job is not yet finished.

“The next two years must be about extracting Palantir from our NHS, not allowing it to become more deeply embedded. NHS trusts and integrated care boards should refuse to expand their use of its platform.”

Now read: Revamp proposed for UK’s emergency alert system